ANIP - ANI Pharmaceuticals Q3 2021 Earnings Preview
ANI Pharmaceuticals (NASDAQ:ANIP) is scheduled to announce Q3 earnings results on Monday, November 1st, before market open. The consensus EPS Estimate is $0.70 (-27.8% Y/Y) and the consensus Revenue Estimate is $49.7M (-6.2% Y/Y). Over the last 2 years, ANIP has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 1 upward revision and 1 downward.
For further details see:
ANI Pharmaceuticals Q3 2021 Earnings Preview